Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

AMYLIN FILES SILENT IPO

Dec. 3, 1991

XOMA TRIES TO BLOCK CENTOXIN

Dec. 3, 1991

TUFTS TO TEST DENSE FIBRILLAR COLLAGEN

Dec. 3, 1991

FDA APPROVES r-GCR FOR PHASE III

Dec. 3, 1991

AGOURON BEGINS TRIALS OF PSORIASIS DRUG

Dec. 3, 1991

GENSIA SPINOFF RAISES $50 MILLION IN IPO

Dec. 2, 1991

CENTOCOR FILES FOR OFFERING FOR TOCOR II

Dec. 2, 1991

APPOINTMENTS AND ADVANCEMENTS

Dec. 2, 1991

BILL PROPOSES ORPHAN DRUG LIMITS

Dec. 2, 1991

GENESIS BUYS INTO DRUG DESIGN TECHNOLOGY

Dec. 2, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...